Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Kaiser, Duke tapped for ARPA-H's $62.7M autonomous AI bid

10 September 2026 · By · Wire by Fusion42

Published

10 September 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at beckerscardiology.com →

◆ Verified

Fusion42 · 10 September 2026 · Fusion42 review

ARPA-H awarded $62.7 million across six teams to develop the first FDA-authorized autonomous AI system for cardiovascular care, focusing on heart failure management with real-world deployments by Duke University and Kaiser Permanente.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

You face a rising regulatory bar as autonomous AI agents for healthcare must gain FDA clearance to operate, shifting compliance into a market-access hurdle rather than a technical problem. Real-world deployments by Kaiser and Duke open clinical data doors you can no longer ignore.

◆ Coverage

1 source · 10 Sep 2026

◆ Related on Wire

◆ Topics

Digital Healtharpa-hautonomous-aicardiovascular-carefda-regulationhealthcare-ai